Cue Biopharma, Inc. Quarterly Common Stock, Shares, Issued from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cue Biopharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q2 2024.
  • Cue Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 48.6M shares, a 11.2% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 48.6M +4.9M +11.2% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 48.6M +5.47M +12.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 47.2M 0 0% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 45.1M +9.74M +27.5% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 43.7M +8.36M +23.6% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 43.2M +9M +26.3% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 47.2M +15M +46.6% Dec 31, 2022 10-K 2024-03-28
Q3 2022 35.4M +4.02M +12.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 35.4M +3.91M +12.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 34.2M +3.67M +12% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 32.2M +1.85M +6.1% Dec 31, 2021 10-K 2023-03-21
Q3 2021 31.4M +1.11M +3.67% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 31.5M +2.17M +7.4% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 30.5M +3.92M +14.8% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 30.4M +3.79M +14.3% Dec 31, 2020 10-K 2022-03-16
Q3 2020 30.3M +7.28M +31.7% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 29.3M +7.99M +37.5% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 26.6M +5.79M +27.9% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 26.6M +5.86M +28.3% Dec 31, 2019 10-K 2021-03-09
Q3 2019 23M +2.84M +14.1% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 21.3M +1.18M +5.88% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 20.8M +652K +3.24% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 20.7M +1.24M +6.36% Dec 31, 2018 10-K 2020-03-12
Q3 2018 20.1M Sep 30, 2018 10-Q 2018-11-13
Q2 2018 20.1M Jun 30, 2018 10-Q 2018-08-13
Q1 2018 20.1M Mar 31, 2018 10-Q 2018-05-14
Q4 2017 19.5M Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.